Below are a series of postings that discuss different aspects of FLC research. Please click on any of the links below to learn more!
- Why rare disease research is important
A perspective on Rare Cancer Day. This year more than 600,000 lives in the US will be lost to cancer. The five most common malignancies account for half of these deaths. Most of the victims … - Immunotherapy roadmap and activities
A new era in cancer therapy dawned in 2011 when the FDA approved ipilimumab (Yervoy) to treat metastatic melanoma. This was the first of a novel class of drugs called immune checkpoint inhibitors (ICIs), which … - Attacking the metabolism of FLC“You are what you eat” is a phrase popularized by the American nutritionist Victor Lindlahr in the 1930s. Of course, the body’s cells have no way to determine whether the nutrients that reach them come …
- Perspectives on FLC immunotherapyBelow is a discussion of the implications of recent research efforts on future FLC immunotherapy treatments as summarized by Mark Furth …
